Watch ARDT. Know when insiders buy.
One email the day a filing lands. Free.
ARDT
Ardent Health, Inc.
12.06
−0.06 −0.50%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
66
PASS · shorts 66
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.7BP/E 21.9DIV YIELD —FCF YIELD —REV TTM $6.4B +3.3%NET INCOME $78.2M −69.3%NET DEBT $391.5M52W 7.83 – 15.21SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.6B | −1.4% | — | — | $16.9M | −76.8% | 0.12 | $196.7M | — | — | Aug 10 |
| Q1 2026 · Mar 31 | $1.6B | +7.0% | — | — | $39.9M | −3.7% | 0.28 | −$60.2M | — | — | Aug 10 |
| Q4 2025 · Dec 31derived | $1.6B | −0.1% | — | — | $45M | −60.6% | 0.32 | $223.4M | — | — | Mar 16 |
| Q3 2025 · Sep 30 | $1.6B | +8.8% | — | — | −$23.5M | −189.2% | -0.17 | $154.4M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $1.6B | +11.9% | — | — | $73M | +70.6% | 0.52 | $117.5M | — | — | Aug 10 |
| Q1 2025 · Mar 31 | $1.5B | +4.0% | — | — | $41.4M | +53.0% | 0.29 | −$24.8M | — | — | Aug 10 |
| Q4 2024 · Dec 31derived | $1.6B | +19.3% | — | — | $114.2M | — | 0.84 | $119.6M | — | — | Mar 16 |
| Q3 2024 · Sep 30 | $1.4B | +5.2% | — | — | $26.3M | +26.3% | 0.19 | $89.7M | — | — | Nov 14 |
| Q2 2024 · Jun 30 | $1.5B | — | — | — | $42.8M | — | 0.34 | $120.4M | — | — | Nov 14 |
| Q1 2024 · Mar 31 | $1.4B | — | — | — | $27M | — | 0.21 | −$14.7M | — | — | Nov 14 |
| Q4 2023 · Dec 31derived | $1.3B | — | — | — | −$4.2M | — | -0.03 | $67.5M | — | — | Mar 16 |
| Q3 2023 · Sep 30 | $1.4B | — | — | — | $20.8M | — | 0.17 | $88.7M | — | — | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $6.3B | — | — | $135.8M | 2.1% | 0.96 | $470.5M | — | — | — | — |
| FY2024 · to Dec 31 | $6B | — | — | $210.3M | 3.5% | 1.58 | $315M | — | — | — | $0 |
| FY2023 · to Dec 31 | $5.4B | — | — | $53.9M | 1.0% | 0.43 | $221.7M | — | — | — | $0 |
| FY2022 · to Dec 31 | $5.1B | — | — | $188.9M | 3.7% | 1.50 | −$38.4M | — | — | — | $174.8M |
Every number comes from Ardent Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.